VALBIOTIS presents the first market data on untreated LDL-hypercholesterolemia for TOTUM-070, and announces the initiation of the Phase II clinical study HEART
VALBIOTIS publishes its 2020 half-year results and provides an update on its global strategic partnership with Nestlé Health Science, its strong financial visibility and the promising advances in its pipeline